This research engineers yeast to convert PET plastic waste into valuable chemicals like PCA, enabling the production of biofuels, pharmaceuticals, and biodegradable materials. By transforming low-value plastic into high-value products, it offers a scalable biotechnological solution to reduce pollution and support the transition to sustainable, circular economies.

IBD patients have weakened gut microbes, leaving them with chronic inflammation and limited treatment options. This research engineers probiotic yeast with anchors, drug-carrying “backpacks,” and reprogrammed DNA to deliver targeted therapeutics safely and cheaply. Early results show these modified microbes could become effective, low-side-effect treatments for IBD and other gut diseases.